34,323 results on '"HYPERTROPHIC CARDIOMYOPATHY"'
Search Results
2. KLHL24 associated cardiomyopathy: Gene function to clinical management
3. A new hypothesis to explain disease dominance
4. Ventricular arrhythmias and the role of antitachycardia pacing in patients with electrical heart disease and hypertrophic cardiomyopathy
5. Leveraging a Vision Transformer Model to Improve Diagnostic Accuracy of Cardiac Amyloidosis With Cardiac Magnetic Resonance
6. A systematic review and meta-analysis on the performance of convolutional neural networks ECGs in the diagnosis of hypertrophic cardiomyopathy
7. Correlation between ECG and MCE findings in HCM patients and clinical implications
8. Identification of SERPINE1 as a therapeutic target in hypertrophic cardiomyopathy via bioinformatics analysis and experimental validation
9. Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals
10. Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis
11. The effect of disopyramide therapy on functional capacity improvement in patients with obstructive hypertrophic cardiomyopathy
12. Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using machine learning
13. A Multicenter Evaluation of the Impact of Therapies on Deep Learning-Based Electrocardiographic Hypertrophic Cardiomyopathy Markers
14. Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics
15. Endpoint Selection in Randomized Clinical Trials for Hypertrophic Cardiomyopathy
16. Prognosis of pulmonary hypertension in patients with hypertrophic cardiomyopathy: A multicenter propensity score matching study
17. The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study
18. Sex differences in the prevalence and survival of pulmonary hypertension in obstructive hypertrophic cardiomyopathy following septal myectomy
19. Low Agreement Among Guidelines for Primary Prevention Implantable Cardioverter-Defibrillator Recommendations in Hypertrophic Cardiomyopathy
20. Managing drug–drug interactions with mavacamten: A focus on combined use of antiarrhythmic drugs and anticoagulants
21. Vigorous exercise and sports participation in individuals with hypertrophic cardiomyopathy
22. Preoperative D-dimer and outcomes in obstructive hypertrophic cardiomyopathy after myectomy
23. Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TNNI3 c.235C > T variant
24. Advances in Cardiovascular Pharmacotherapy. I. Cardiac Myosin Inhibitors
25. Hypertrophic cardiomyopathy: Current understanding and emerging therapeutics
26. Implications of primary bradycardia in patients with hypertrophic cardiomyopathy
27. Long-Term Impact of Pregnancy on Clinical Outcomes in Individuals With Hypertrophic Cardiomyopathy
28. Patient-specific hiPSC-derived cardiomyocytes indicate allelic and contractile imbalance as pathogenic factor in early-stage Hypertrophic Cardiomyopathy
29. Morphological anomalies in obstructive hypertrophic cardiomyopathy: Insights from four-dimensional computed tomography and surgical correlation
30. Cardiovascular causes of pediatric chest pain: Case-based review
31. Machine-learning computer-assisted ECG analysis to predict myocardial fibrosis in patients with hypertrophic cardiomyopathy
32. The Efficacy and Safety of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials
33. Genotype-phenotype correlations in hypertrophic cardiomyopathy: Insights from an HCM Center of Excellence
34. Segmental myocardial tissue remodeling and atrial arrhythmias in hypertrophic cardiomyopathy: Findings from T1-mapping MRI
35. Duality in disease: How two amino acid substitutions at actin residue 312 result in opposing forms of cardiomyopathy
36. Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
37. Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy
38. Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
39. Family Screening in Hypertrophic Cardiomyopathy: Identification of Relatives With Low Yield From Systematic Follow-Up
40. Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy
41. Evaluating the Prevalence of Cardiac Surgery–associated Acute Kidney Injury After Septal Myectomy Combined With Concomitant Procedures in Obstructive Hypertrophic Cardiomyopathy
42. Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: Observations from a tertiary care center
43. Spectrum and genotype–phenotype relationship of ALPK3 variants in Chinese patients with hypertrophic cardiomyopathy
44. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
45. Transapical beating-heart septal myectomy for hypertrophic cardiomyopathy patients with midventricular obstruction
46. Extracellular vesicles in cardiomyopathies: A narrative review
47. Three-dimensional echocardiography reveals early mitral valve alterations in hypertrophic cardiomyopathy genetic mutation carriers
48. Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy
49. The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre
50. Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.